--- title: "SOMERSET THERAPEUTICS LLC Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search SOMERSET THERAPEUTICS LLC recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/somerset-therapeutics-llc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # SOMERSET THERAPEUTICS LLC recall records **5** reported ongoing 6 records in this archive. Latest source date Feb 4, 2026. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Feb 4, 2026 FDA drug enforcement ### [Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 0887...](https://isitonrecall.com/recall/fda-drug-d-0398-2026-dexamethasone-sodium-phosphate-injection-usp-100-mg-10-ml-10-mg-ml-10x10-ml-multiple-dose-vials-rx-o/) Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexame... Class II Reported ongoing Distribution: Nationwide in the USA [Official source for Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0398-2026%22) Nov 26, 2025 FDA drug enforcement ### [Cisatracurium Besylate Injection USP, 10 mg/5 mL\* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, M...](https://isitonrecall.com/recall/fda-drug-d-0236-2026-cisatracurium-besylate-injection-usp-10-mg-5-ml-2mg-ml-10-x-5-ml-single-dose-vials-per-carton-rx-onl/) Subpotent product:out of specification assay results observed during long term stability testing. Class III Reported ongoing Distribution: Nationwide in the USA [Official source for Cisatracurium Besylate Injection USP, 10 mg/5 mL\* (2mg/mL), 10 x 5 mL Single-dose Vials per Carto...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0236-2026%22) Nov 26, 2025 FDA drug enforcement ### [Cisatracurium Besylate Injection USP, 200mg/20mL\*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, ...](https://isitonrecall.com/recall/fda-drug-d-0237-2026-cisatracurium-besylate-injection-usp-200mg-20ml-10mg-ml-10-x-20-ml-single-dose-vials-per-carton-rx-o/) Subpotent product:out of specification assay results observed during long term stability testing. Class III Reported ongoing Distribution: Nationwide in the USA [Official source for Cisatracurium Besylate Injection USP, 200mg/20mL\*(10mg/mL), 10 x 20 mL Single-dose Vials per Cart...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0237-2026%22) Nov 26, 2025 FDA drug enforcement ### [Cisatracurium Besylate Injection USP, 20 mg/10 mL\*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 330...](https://isitonrecall.com/recall/fda-drug-d-0238-2026-cisatracurium-besylate-injection-usp-20-mg-10-ml-2-mg-ml-10-x-10-ml-multiple-dose-vials-per-carton-r/) Subpotent product:out of specification assay results observed during long term stability testing. Class III Reported ongoing Distribution: Nationwide in the USA [Official source for Cisatracurium Besylate Injection USP, 20 mg/10 mL\*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0238-2026%22) Dec 16, 2024 FDA drug enforcement ### [Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01](https://isitonrecall.com/recall/fda-drug-d-0169-2025-atropine-sulfate-ophthalmic-solution-usp-1-5-ml-bottles-rx-only-manufactured-for-somerset-therapeuti/) Failed Impurities/Degradation Specifications Class III Reported terminated Distribution: Nationwide within the United States [Official source for Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset T...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0169-2025%22) Apr 24, 2024 FDA drug enforcement ### [Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC 70069-381-10), Rx only, Manufactured for: ...](https://isitonrecall.com/recall/fda-drug-d-0506-2024-haloperidol-decanoate-injection-50mg-ml-packaged-in-a-1-ml-single-dose-vials-ndc-70069-381-01-and-b/) Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI). Class II Reported ongoing Distribution: Nationwide within the United States [Official source for Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01)...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0506-2024%22) ## Reasons in these listed records - Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate. - Subpotent product:out of specification assay results observed during long term stability testing. - Failed Impurities/Degradation Specifications - Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI). These examples come from this result page and are not a ranking of every recall reason. ## Checking SOMERSET THERAPEUTICS LLC ### Is there a recall on somerset therapeutics llc right now? This archive contains 6 records, including 5 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search SOMERSET THERAPEUTICS LLC](https://isitonrecall.com/check/?q=SOMERSET%20THERAPEUTICS%20LLC) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)